Many naturally occurring and man-made chemicals present in the environment possess estrogenic activity. Examples include plant and fungal products, pesticides, plasticizers, and other agricultural and industrial chemicals. These environmental estrogens as well as endogenous ovarian estrogens are thought to initiate their physiological actions in target tissues largely via interactions with a nuclear receptor system. The resultant estrogen-receptor complex in turn affects transcription via its interactions with nucleotide sequences known as estrogen response elements (EREs) present in the regulatory regions of hormone responsive genes. A "consensus" ERE sequence GGTCAnnnTGACC was originally identified in the vitellogenin genes of birds and amphibians, but it is now clear that most naturally occurring EREs differ from this sequence in one or more bases. We and others have obtained both in vivo and in vitro data suggesting a differential interaction of receptor complexes containing different ligands with the multiple EREs present in mammalian systems. This raises the possibility that the toxicity of environmental estrogens may arise in part from a differential pattern of ERE activation by environmental compounds relative to endogenous ovarian estrogens. The experimental basis for such a paradigm and its toxicological implications are discussed in this paper. -Environ Health Perspect 103(Suppl 7): 29-33 (1995) 
Introduction
It has been recognized for some time that a number of chemicals in the environment possess estrogenic activity in a variety of biological systems. These compounds include plant and fungal products, pesticides, plasticizers, estrogenic agents administered to livestock, and a variety of other chemicals (1, 2) . As these agents are capable of perturbing the normal hormonal milieu in humans and other animals, they can be properly considered as environmental toxicants. Similarly, it is clear that the pharmacological use of ovarian estrogens and synthetic compounds such as diethylstilbestrol (DES) can cause toxicity, e.g., the endometrial cancer seen in women receiving unopposed estrogens (3) and reproductive tract abnormalities in women exposed to DES in utero (4) . For ease of discussion, we will refer to all such environmental and pharmacological compounds as environmental estrogens. What then is the mechanism of toxicity of such environmental estrogens?
One straightforward possibility is that these compounds alter the physiological patterns of target tissue function, proliferation, and development normally regulated by ovarian estrogens such as estradiol. The basic idea here is that exposure to these compounds is simply like being exposed to too much of an endogenous estrogen produced by the ovary. For example, environmental estrogens could interact with estrogen receptors in the hypothalamic/ pituitary axis to alter circulating gonadotropin levels and affect reproductive function in both males and females. Such effects on differentiated function have been suggested as a possible mechanistic basis for the decrease in human sperm counts recently reported (5) . A second example would be the increase in endometrial cancer resulting from the pharmacological use of unopposed estrogens for hormone replacement therapy in postmenopausal women (3) . Since estrogens increase endometrial proliferation, this toxicity could result simply from an increased level of DNA replication by increasing the probability of introducing mutations into the genome due to mismatch errors. Alternatively, one The paradigm noted above originally occurred to us from our studies on the EREs of hormone target genes. By way of background, the majority of experimental studies on EREs have used the so-called consensus ERE (c-ERE) originally identified in the vitellogenin genes of xenopus and chickens (9, 10) . This element is a 13-mer palindromic sequence, GGTCAnnnTGACC, that binds the estrogen receptor as a homodimer, confers estrogen inducibility to target genes, and is located in the 5'-flanking region of the endogenous genes (9-12). More recently, we and numerous other groups initiated studies to identify the EREs in other genes regulated physiologically by estrogens.
Our own work has focused on c-fos, cjun, and other members of the AP-1 family of transcription factors, whose expression is regulated by physiological levels of estradiol in intact animals. Transcript levels of these genes are rapidly activated in the rodent uterus following in vivo administration of estradiol, and several studies suggested that this was a direct transcriptional effect of the hormone (13, 14) . Based upon the location of EREs in the vitellogenin gene and other genes, we initially searched the 5'-upstream region of the murine c-fos gene for a functional element but were unsuccessful. We next examined other regions of the gene and identified a functional ERE in the 3'-untranslated region of the gene approximately 6 kilobases (kb) from the start site of transcription (15) . This element binds the estrogen receptor in cell-free band-shift assays (15, 16) and confers hormonal responsiveness to both homologous and heterologous promoters (15) . Interestly, the fos ERE has the sequence GGTCAnnnCAGCC, which contains one-half site (GGTCA) identical to that in the c-ERE but a second half site that is quite different (TGACC in the c-ERE vs CAGCC in the fos ERE).
More recently, we have identified a functional ERE in the rat c-jun gene that binds the estrogen receptor and confers hormonal inducibility (17) . This element is located in the single exon of the jun gene and has the sequence GCAGAnnnTGACC. This sequence again has one-half site (TGACC) that is identical to that in the c-ERE, but the other half site differs in 3 of 5 positions.
Our results with c-fos and c-jun indicated that the EREs for these genes vary considerably in sequence and location from that of the consensus element and prompted us to examine the literature for EREs located in other hormone responsive genes. Table 1 lists a number of EREs that have been reported to date. Upon viewing this information, it was somewhat surprising to us to realize that the consensus ERE is present only in the vitellogenin gene of xenopus and chicken and that all other elements identified to date contain one to three changes in the 10 bases comprising the palindromic half sites of the c-ERE. The most common pattern, seen in all but two cases, is an element with one-half site identical to the c-ERE, and a second nonidentical half site. A possible example of such differential selectivity was provided by the studies of Korach and his colleagues (38) (39) (40) who examined several different uterotropic responses (induction of DNA synthesis, glucose-6-phosphate dehydrogenase activity, and progesterone receptor levels) following in vivo administration of a series of diethylstilbestrol (DES) analogs. They observed that the measured parameters showed differential patterns of responsiveness to the series of DES analogs and suggested that "the ability of a particular response to be increased may depend on the chemical nature of the ligand receptor complex and its interaction at genomic sites" (38) . These results are certainly consistent with the possibility that complexes formed between the estrogen receptor and different DES analogs exhibit selective activation of distinct ERRs present in various hormone-responsive genes.
We (41) While tamoxifen is an antiestrogen in some systems, in the rat uterus it acts primarily as an estrogen agonist following acute administration; several studies have recently reported that tamoxifen and estradiol elicit different patterns of expression of fos and jun family members in this system (43, 44) . Some of these differences, such as the length of time that expression of some genes remains elevated, can be explained on the basis of pharmacokinetic differences in the two compounds. However, differences in the initial patterns of gene expression are more difficult to explain without postulating selective patterns of gene activation by the estrogen-receptor versus tamoxifen-receptor complexes.
Perhaps the clearest example of this possiblity to date comes from a recent series of experiments from Brooks and his colleagues (45) (46) (47) . They examined the ability of a series of estradiol analogs to bind to the estrogen receptor and elicit biological responses including induction of the progesterone receptor, pS2 mRNA, cathepsin D mRNA, and CAT activity from reporter constructs containing the c-ERE. They found clearly different patterns of activation of these responses by the different estrogen analogs (45) (46) (47) and emphasized the possible biological significance of these observations.
Discussion and Implications for Toxicity of Environmental Estrogens
Taken together, these findings suggest that the toxicity of environmental estrogens could involve a number of factors and could occur via several related but distinct mechanisms. The first and most obvious type of toxicity could be that in which an environmental estrogen binds to the estrogen receptor and produces an estrogenic response. Toxicity in this case is simply due to hyperestrogenism, i.e., an extension of the physiological effects of estrogenic hormones.
A second type of toxicity, which has been proposed, is that some estrogens could also produce toxicities by virtue of their chemical rather than their hormonal properties. For example, it has been shown that administration of estrogens to certain species leads to the formation of DNA adducts (48) . While not discussed in this manuscript, we note this possibility for completeness.
In this manuscript we suggest that a third, more subtle, type of toxicity could result if an environmental estrogen produced an imbalanced estrogenic response in a target tissue. As discussed above, this could occur in one of two basic ways. First, an environmental estrogen such as a pesticide, a phytoestrogen produced by plants, a plasticizer, etc., might bind to the estrogen receptor and produce a different conformation than estradiol. In this case, the resulting receptor-ligand complex might selectively activate/repress estrogen responsive genes differently than the naturally occurring ovarian hormone. Rather than simply creating a situation of too much estrogenic stimulation (which might be ameliorated by compensatory homeostatic mechanisms involving the hypothalamic-pituitary-gonadal axis), the result might be a qualitatively distinct state of estrogenizatlon.
An imbalanced estrogenic response might also occur due to the possibility that estrogenic responses may exhibit different dose-response curves as illustrated in Figure 1 'Estrogens' Figure 1 . Hypothetical dose-response curves for two estrogen-regulated genes in the presence of estradiol alone (E2) and in the presence of estradiol plus an environmental estrogen (E2 + EE).
in the system (point E2 + EE), the ratio of the two genes products now becomes 1:1. The net result of such effects could be an imbalance in the levels of hormonally regulated growth factors, growth factor receptors, protooncogenes, and other key molecules in target cells. Such an altered profile of regulatory molecules could lead to abnormal proliferative and differentiative properties of hormone responsive cells. This might be particularly deleterious during critical developmental periods when cells may be especially sensitive to alterations in regulatory systems.
Many of the suggestions outlined in this discussion are admittedly hypothetical and speculative and will require much additional work to substantiate or refute. We also recognize that one can propose various other models which could equally well explain some of the observations such as multiple dose-response curves that we have discussed, e.g., the existence of cell membrane as well as intranuclear receptors as suggested by others. However, the ideas we have discussed stem from ongoing projects in our labs, which indicate that estrogen response elements are more diverse than we had previously appreciated, and we elected to offer them here to stimulate discussion and offer new perspectives on the possible mechanisms involving the toxicity of environmental estrogens.
